S.A. Health Authority Warns of Dangerous Counterfeit Diabetes Medication

14 November, 2024

The South African Health Products Regulatory Authority has sounded the alarm over counterfeit diabetes medication. There is a rise in particularly GLP-1 products like Ozempic, being sold through unauthorised channels. SAHPRA’s Madimetja Mashishi says these fake medications pose serious health risks as they lack quality checks. He urges the public to buy only registered products:

S.A. Health Authority Warns of Dangerous Counterfeit Diabetes Medication Leonard Witbeen

Written by: Leonard Witbeen

counterfeit diabetes medication diabetes treatment fake medications GLP-1 products Health Awareness health risks Madimetja Mashishi medication regulation Ozempic pharmaceutical safety Public Safety quality checks registered products SAHPRA South African Health Products Regulatory Authority unauthorized channels

Biosafety Act of 2006 requires review and modernisation says Aupindi

By: Selma Taapopi Chairperson of the Parliamentary Standing Committee on Natural Resources, Tobie Aupindi, says the Biosafety Act of 2006 (Act No. 7 of 2006) and its subsequent regulations have served Namibia well over the years. He however noted that rapid scientific advancements have exposed the need to review and […]

24 February, 2026